UCLA researchers received a $12 million grant to start clinical trials of a new treatment for advanced-stage lung cancer. The California Institute for Regenerative Medicine, an organization that funds stem cell research to accelerate advances in medicine, awarded the grant to the labs of Steven Dubinett, the director of the UCLA Jonsson Comprehensive Cancer Center’s lung cancer research program, and Edward Garon, an associate professor of hematology and oncology at the David Geffen School of Medicine, on Thursday. Read more...

Photo: The California Institute for Regenerative Medicine is funding clinical trials at UCLA that involves the injection of drugs optimized for each patient to treat tumors. (Daily Bruin File Photo)

UCLA microbiologists have developed vaccines against anthrax and other diseases likely to be used in bioterrorist attacks. In a study published May 3, UCLA researchers developed a platform for creating vaccines against three Tier 1 select agents, bacteria responsible for diseases such as anthrax, tularemia and plague. Read more...

Local community college students toured UCLA laboratories and attended transfer admission workshops and panels Saturday as part of an effort to promote diversity in the sciences. Read more...

Photo: The Organization for Cultural Diversity in Science (OCDS), which aims to empower underrepresented groups in the sciences, held a Spring Science and Engineering Showcase to encourage community college students to pursue STEM in higher education. (Amy Dixon/Assistant photo editor)

A patient in the Ronald Reagan UCLA Medical Center’s medical intensive care unit was able to watch the sunset on the hospital’s outdoor patio on his last day alive despite it being against traditional medical practices, thanks to a new medical program. Read more...

Photo: The 3 Wishes Project grants wishes to terminally ill patients in UCLA’s medical ICU as part of a multicenter research trial started in Canada in December 2017. (Courtesy of Thanh Neville)

Surgery might have a decadeslong learning curve, according to a UCLA-led study. Researchers found that patients treated by older surgeons had lower death rates within 30 days of their procedures than those treated by younger surgeons. Read more...

Photo: Researchers found that patients treated by older surgeons had lower death rates within 30 days of their procedures than those treated by younger surgeons. (Niveda Tennety/Daily Bruin)